June 19, 2018

REV•1 Engineering To Speak at Drug/Device Combination Product Summit

Phil Burke to Present “Best Practices” for Device Development with Drug/Device Combination Products at Boston Summit. MURRIETA, Calif. – June 19, 2018 – (FOR IMMEDIATE RELEASE) — REV•1 Engineering will be presenting “Accelerating Along the Critical Path – Identifying Best Practices for De-Risking Device Development for Combination Products” at the Combination Product Life Cycle Management Summit in Boston, MA, June 19th – 21st. Combination products integrate a medical device for the delivery of a therapeutic drug.  Examples can be […]
June 11, 2018

Is Your Innovation Strategy Incremental or Transformational?

I recently had the opportunity to read CB Insights’ 2018 State of Innovation report on the perspectives of nearly 700 senior strategy executives, globally.  As the person in charge of strategic development at a company that specializes in Development and Innovation (D&I), I found the report quite interesting. I’d like to share some of their findings… The survey identified nearly 85% of strategy executives believe innovation is very important to the future performance of their […]
April 25, 2018
REV.1 Engineering Medical Device Development Team

The Strategic Risk of Engineering Talent Turnover

Do You Have Contingencies in Place to Counter Disruption from the Coming Talent Wars? It’s a topic that’s been front and center since our recovery from the Great Recession: How will companies that depend on knowledge workers for value creation react to the inevitable talent wars? Due to the growing complexity and sophistication of our products, perhaps no other segment is more vulnerable to disruption than the medical device industry. And perhaps no place is […]
April 12, 2018
Internal Drug Delivery Device

De-Risking the Development of Drug/Device Combination Products

Navigating the Critical Path with Combination Products A market research study, published earlier this week by Market.Biz, illustrates the promise of what is perhaps the most dynamic technology segment emerging in healthcare; combination products. The research pegged the value of the combination products market at $64.7 billion in 2017, and projects a CAGR (current annual growth rate) of 13.8% through 2023, escalating the market value to a staggering $94.5 billion by that time. One of […]
X
Schedule a Conversation
Contact Us